All Fields
Computer Science
Medicine
FAQ
Contact
Sign in
SB 258719
Known as:
SB-258719
Â
Â
Topic mentions per year
Topic mentions per year
1998-2016
0
1
2
3
1998
2016
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltramadol, via activation of descending serotonergic…
Omer YanarateÅŸ
,
Ahmet Bulent Dogrul
,
+7 authors
Ulku Aypar
Anesthesiology
2010
BACKGROUND Tramadol is an analgesic drug, and its mechanism of action is believed to be mediated by the mu-opioid receptor. A…Â
(More)
Is this relevant?
2010
2010
Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity.
Alex Brenchat
,
Xavier Nadal
,
+12 authors
José Miguel Vela
Pain
2010
The involvement of the 5-HT(7) receptor in nociception and pain, particularly chronic pain (i.e., neuropathic pain), has been…Â
(More)
Is this relevant?
2009
2009
5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice.
Alex Brenchat
,
Luz Romero
,
+8 authors
José Miguel Vela
Pain
2009
This work aimed to evaluate the potential role of the 5-HT(7) receptor in nociception secondary to a sensitizing stimulus in mice…Â
(More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.
Martin R Guscott
,
Linda J. Bristow
,
+15 authors
G. McAllister
Neuropharmacology
2005
The affinity of several antidepressant and antipsychotic drugs for the 5-HT7 receptor and its CNS distribution suggest potential…Â
(More)
Is this relevant?
2004
2004
Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
Cécile Mahé
,
Erika Loetscher
,
Dominik Feuerbach
,
Werner Müller
,
Max P Seiler
,
Philippe Schoeffter
European journal of pharmacology
2004
Recombinant 5-hydroxytryptamine 5-HT7 receptors are known to express constitutive, i.e., agonist-independent activity…Â
(More)
Is this relevant?
2004
2004
A 5-HT7 Heteroreceptor-Mediated Inhibition of [3H]Serotonin Release in Raphe Nuclei Slices of the Rat: Evidence for a Serotonergic–Glutamatergic Interaction
László Gábor Hársing
,
Ibolya Prauda
,
József Barkóczy
,
Péter Mátyus
,
Zsolt Jurányi
Neurochemical Research
2004
Midbrain slices containing the dorsal and medial raphe nuclei were prepared from rat brain, loaded with [3H]serotonin ([3H]5-HT…Â
(More)
Is this relevant?
2004
2004
Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy.
Márton Gráf
,
Rita Jakus
,
Sandor Kantor
,
Gyorgy Levay
,
Gyorgy Bagdy
Neuroscience letters
2004
Recent studies have provided evidence that activation of 5-HT1A receptors increases epileptic activity in the WAG/Rij rat model…Â
(More)
Is this relevant?
2003
2003
The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor.
Martin R Guscott
,
Elizabeth S. Egan
,
+8 authors
Peter H. Hutson
Neuropharmacology
2003
The 5-HT(7) receptor is a recent addition to the 5-HT receptor family and to date there is no clear idea as to its potential role…Â
(More)
Is this relevant?
1999
1999
5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors.
D. R. Thomas
,
Derek N. Middlemiss
,
Sara Taylor
,
Peter Nelson
,
A. M. Brown
British journal of pharmacology
1999
1. A number of compounds, including the selective 5-HT7 receptor antagonist SB-258719, were investigated for their effect on [3H…Â
(More)
Is this relevant?
1998
1998
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
D. R. Thomas
,
Sandra Gittins
,
+7 authors
A. M. Brown
British journal of pharmacology
1998
1. The functional profile of the long form of the human cloned 5-HT7 receptor (designated h5-HT7(a)) was investigated using a…Â
(More)
Is this relevant?